Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of BCL6 mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene results in increased expression of BCL6 mRNA | increases expression | 20406850
|
C026114 |
2-xylene |
2-xylene results in increased expression of BCL6 mRNA | increases expression | 20359517
|
C075773 |
4-phenylbutyric acid |
4-phenylbutyric acid results in increased expression of BCL6 mRNA | increases expression | 14583596
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of BCL6 mRNA | affects expression | 15606129
|
C430898 |
AGN 194204 |
AGN 194204 results in decreased expression of BCL6 mRNA | decreases expression | 15302862
|
D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite results in increased expression of BCL6 mRNA | increases expression | 18687144
|
D001554 |
Benzene |
Benzene results in increased expression of BCL6 mRNA | increases expression | 20359517
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of BCL6 mRNA | increases expression | 20713471
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in decreased expression of BCL6 mRNA | decreases expression | 17484886
|
D002251 |
Carbon Tetrachloride |
PLG gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of BCL6 mRNA] | increases expression|increases reaction | 16006527
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of BCL6 mRNA | decreases expression | 20106945
|
C004912 |
ethylbenzene |
ethylbenzene results in increased expression of BCL6 mRNA | increases expression | 20359517
|
C056507 |
gemcitabine |
gemcitabine results in increased expression of BCL6 mRNA | increases expression | 17039268
|
C029424 |
hydrazine |
hydrazine results in decreased expression of BCL6 mRNA | decreases expression | 15282401
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in decreased expression of BCL6 mRNA | decreases expression | 19675145
|
D008748 |
Methylcholanthrene |
Methylcholanthrene results in increased expression of BCL6 mRNA | increases expression | 20713471
|
D008752 |
Methylene Chloride |
Methylene Chloride results in increased expression of BCL6 mRNA | increases expression | 20359517
|
C016599 |
mono-(2-ethylhexyl)phthalate |
mono-(2-ethylhexyl)phthalate results in increased expression of BCL6 mRNA | increases expression | 16809437
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of BCL6 mRNA | affects binding|increases activity|increases expression | 19710929
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of BCL6 mRNA | increases expression | 18445702
|
D011374 |
Progesterone |
Progesterone results in decreased expression of BCL6 | decreases expression | 17510236
|
D020849 |
Raloxifene |
Raloxifene results in increased expression of BCL6 mRNA | increases expression | 16497877
|
C059514 |
resveratrol |
resveratrol results in decreased expression of BCL6 protein | decreases expression | 17088997
|
C059514 |
resveratrol |
resveratrol results in increased expression of BCL6 mRNA | increases expression | 12002526 12569576
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of BCL6 mRNA | increases expression | 12760830
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of BCL6 mRNA | decreases expression | 18684927
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of BCL6 mRNA | increases expression | 17035482
|
D014050 |
Toluene |
Toluene results in increased expression of BCL6 mRNA | increases expression | 20359517
|
D014241 |
Trichloroethylene |
Trichloroethylene results in increased expression of BCL6 mRNA | increases expression | 20359517
|
D014415 |
Tunicamycin |
Tunicamycin results in increased expression of BCL6 mRNA | increases expression | 17127020
|
C034028 |
vanadyl sulfate |
vanadyl sulfate results in decreased expression of BCL6 mRNA | decreases expression | 16330358
|
D014810 |
Vitamin E |
Vitamin E results in decreased expression of BCL6 mRNA | decreases expression | 19244175
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.59 | 11752688 15322242 14514962 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
3.62 | 16538975 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
8.23 | 18653653 11850527 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
8.23 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
1.92 | 20464547 20127859 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
10.41 | 6695378 |
MESH:D000236 |
Adenoma |
|
Methylcholanthrene |
10.41 | 10545420 6695378 |
MESH:D000236 |
Adenoma |
|
resveratrol |
10.41 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
9.02 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
9.02 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.43 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.64 | 17306315 16712894 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
4.34 | 17308373 17451421 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
4.21 | 15800139 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
4.21 | 16162502 16183991 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.72 | 11748828 |
MESH:D000741 |
Anemia, Aplastic |
|
Benzene |
4.17 | 14761424 17661222 11369114 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.58 | 10982225 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.82 | 19183758 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
3.34 | 17115116 |
MESH:D050197 |
Atherosclerosis |
|
Methylcholanthrene |
6.45 | 11922910 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
6.45 | 16873680 17967414 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.44 | 18445737 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
7.99 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
7.99 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
2-xylene |
11.21 | 7457028 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
11.21 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.60 | 15746008 |
MESH:D001855 |
Bone Marrow Diseases |
|
Benzene |
4.96 | 16183116 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.07 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
10.11 | 15845082 15380490 15665606 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
10.11 | 16580743 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
4.02 | 17600658 |
MESH:D001943 |
Breast Neoplasms |
|
Benzene |
6.72 | 17162533 11921183 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
6.72 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
gemcitabine |
6.72 | 18382427 17039268 |
MESH:D001943 |
Breast Neoplasms |
|
Methylcholanthrene |
6.72 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Methylene Chloride |
6.72 | 15986119 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
6.72 | 16175315 15562024 17614352 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
6.72 | 17893378 16912660 15775269 17242785 15758505 15572757 17440819 17595753 16837676 17261762 17952589 17049068 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
6.72 | 16393696 17534123 17651959 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
6.72 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Trichloroethylene |
6.72 | 15986119 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
9.08 | 15721981 18705752 15700767 16097048 16192424 3786805 16050911 16124888 16227642 10355542 15673190 16011737 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Vitamin E |
9.08 | 16050911 |
MESH:D002277 |
Carcinoma |
|
Methylcholanthrene |
7.65 | 10545420 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
7.65 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
10.79 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
10.79 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
10.79 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
10.79 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
10.79 | 19321006 16227395 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
10.79 | 15276417 17306315 16507464 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.33 | 16675471 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
7.10 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
7.10 | 16227395 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
7.10 | 18572023 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
3.85 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.22 | 16120746 18670907 18850075 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
6.97 | 15775269 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
6.97 | 15458977 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.43 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
14.58 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
14.58 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylcholanthrene |
14.58 | 16192471 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
14.58 | 20056578 19524636 |
MESH:D002547 |
Cerebral Palsy |
|
Toluene |
5.59 | 9294310 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.94 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
7.12 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.12 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
1.99 | 15340226 12621046 8697196 15668235 16354765 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.36 | 15800139 |
MESH:D003092 |
Colitis |
|
resveratrol |
3.87 | 16474422 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
2.41 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
2.22 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.84 | 17141729 14669216 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.59 | 16507316 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Benzene |
5.22 | 15643154 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
5.22 | 10048152 20055451 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Toluene |
5.22 | 9294310 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin E |
5.22 | 19769572 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
10.03 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
10.03 | 18551238 |
MESH:D003643 |
Death |
|
Toluene |
5.40 | 6431079 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
3.94 | 17474826 |
MESH:D003872 |
Dermatitis |
|
Benzene |
4.51 | 15902427 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.30 | 18249437 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
8.09 | 16873680 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
vanadyl sulfate |
8.09 | 16684804 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.61 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
8.48 | 17451421 15920148 17308373 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
8.48 | 16286809 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.23 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
14.19 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
14.19 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
14.19 | 16109766 11743745 16081117 14550746 11287661 14725611 19739265 18713872 12705907 19416960 18071297 11461765 10915739 16781746 16177239 11739529 15968718 11834606 19085960 12540782 17906064 19923254 14986274 10774834 12153990 16393943 16485898 10663392 16227642 17522070 12958197 12392966 19164858 2444490 15619225 12594235 19420014 19370779 11421492 17562736 11529661 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
14.19 | 2869522 15998439 9327722 7179309 19085960 6884620 16227642 15027814 7440962 3732212 16177239 10915739 19336974 10092053 4309450 21278145 15968718 17522070 7120509 6623471 3786805 11566570 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
14.19 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Trichloroethylene |
14.19 | 7120509 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.83 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.57 | 11462148 |
MESH:C538011 |
Eales disease |
|
Vitamin E |
4.44 | 9068938 |
MESH:D004487 |
Edema |
|
pirinixic acid |
14.53 | 12083418 |
MESH:D004487 |
Edema |
|
Raloxifene |
14.53 | 15860553 |
MESH:D004487 |
Edema |
|
resveratrol |
14.53 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
14.53 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.64 | 15322242 18230668 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
14.04 | 17692515 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
14.04 | 15845917 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
14.04 | 17872969 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
8.17 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
8.17 | 9294722 10568697 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
4.13 | 15821434 17637181 15328337 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.59 | 17923197 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
1.94 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.82 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
16.84 | 16239168 61145 17595544 12795759 15959796 16045604 12631006 19224547 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
16.84 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
16.84 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
16.84 | 17473493 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.20 | 11858732 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
3.79 | 9205823 11852909 |
MESH:D005354 |
Fibrosarcoma |
|
Methylcholanthrene |
4.68 | 10962813 14633661 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
13.22 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
13.22 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
13.22 | 20067830 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.41 | 16983495 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.42 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.95 | 8708960 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.33 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
10.30 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
10.30 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin E |
10.30 | 16080930 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
3.36 | 11110106 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.38 | 20558911 |
MESH:D006402 |
Hematologic Diseases |
|
Benzene |
4.41 | 16183116 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.16 | 15720958 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
4.16 | 16366002 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.10 | 11000095 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.35 | 19110552 19900420 |
MESH:D006529 |
Hepatomegaly |
|
2-xylene |
13.09 | 7457028 7457013 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
13.09 | 16221962 18467677 19176532 19772884 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
13.09 | 12621046 15340226 16120746 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin E |
2.61 | 16490937 16863852 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
3.92 | 16876885 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
2.94 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Vitamin E |
3.71 | 14716179 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.78 | 15340226 16354765 8697196 16959395 18606429 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.50 | 16870215 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.27 | 16899240 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
3.77 | 17188708 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
2.96 | 20558911 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
3.79 | 16873680 |
MESH:D006973 |
Hypertension |
|
Benzene |
11.55 | 17940673 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
11.55 | 10903974 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
11.55 | 15787275 17577099 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
11.55 | 18670907 18850075 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.83 | 15338365 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
4.07 | 17488730 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
10.63 | 15869954 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
10.63 | 17600658 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
2.82 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
10.87 | 9205823 17237260 17963957 12878042 17255318 |
MESH:D007249 |
Inflammation |
|
Progesterone |
10.87 | 15869954 |
MESH:D007249 |
Inflammation |
|
resveratrol |
10.87 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
10.87 | 12200463 12878042 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
10.20 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Vitamin E |
10.20 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.46 | 16306350 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
4.39 | 17255318 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.10 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.17 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
13.18 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
13.18 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
13.18 | 20008137 |
MESH:D007674 |
Kidney Diseases |
|
Vitamin E |
13.18 | 12488133 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
11.14 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
11.14 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
11.14 | 12371664 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.25 | 16973256 |
MESH:D007938 |
Leukemia |
|
Benzene |
3.26 | 14694614 18335105 17119257 15935818 |
MESH:D007951 |
Leukemia, Myeloid |
|
Benzene |
4.08 | 17506065 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Benzene |
2.65 | 19478238 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
3.41 | 16087638 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
4.43 | 15821434 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
2.67 | 21278145 17157831 17334410 16943688 17174718 16239168 11408273 16221502 11903743 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
6.36 | 18429990 17922224 15123356 14716496 11481614 15818738 15362042 18420326 18481824 14620537 18339082 18054572 18187930 17761835 18166357 17698563 16116963 18395095 18705752 15052691 15057751 15370692 18317297 15931870 17944888 17708605 12632512 14512876 16192424 17976157 17631135 17481882 17565644 17900296 15996030 15959796 16011737 15925388 16027843 18251166 15650968 16638106 15893842 14748882 10355542 12609069 12586293 18472332 12741479 12666154 17721639 16033810 14724832 17869086 18279442 18277467 17766677 16136751 18205269 14716833 20821823 12649538 18210741 16097048 12546737 18263696 12667390 16015684 13678700 18006644 17525996 12389079 12445421 12445418 17805973 18472094 15673190 17823541 17640975 18376398 17714472 12632514 15876570 15338365 12958196 18395914 18418968 18156304 17557913 18412020 15730626 12898905 16248980 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
6.36 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
6.36 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
6.36 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin E |
6.36 | 16169303 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
3.66 | 19784758 16611625 19014921 12969438 19460945 11587558 16610002 12587719 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
3.66 | 16964402 15830285 15720792 16246199 17285989 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.91 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
8.65 | 16871587 17185352 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
8.65 | 14706259 16899240 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
20.34 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
20.34 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
20.34 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
20.34 | 16377806 20007298 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
20.34 | 20405173 19812893 19073162 19321006 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
20.34 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
20.34 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
21.27 | 6135515 2876786 2876784 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Benzene |
21.27 | 12562636 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
21.27 | 12014681 15583823 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Methylcholanthrene |
21.27 | 1399818 598648 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
21.27 | 12151625 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Trichloroethylene |
21.27 | 7955063 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
6.86 | 19095001 |
MESH:D008171 |
Lung Diseases |
|
Vitamin E |
6.86 | 16863852 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Benzene |
4.54 | 14698565 |
MESH:D055370 |
Lung Injury |
|
Asbestos, Crocidolite |
8.45 | 17365036 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
8.45 | 21114838 |
MESH:D008175 |
Lung Neoplasms |
|
Benzene |
10.17 | 12562636 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
10.17 | 18569708 17053015 20464547 20869020 18816296 18520028 20135361 6695378 20064080 |
MESH:D008175 |
Lung Neoplasms |
|
Methylcholanthrene |
10.17 | 16271038 10545420 9230183 21163286 15390079 1399818 16337739 6695378 7750092 20512841 20970405 17909032 11893704 |
MESH:D008175 |
Lung Neoplasms |
|
Methylene Chloride |
10.17 | 15172992 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
10.17 | 17077188 15276417 17306315 16712894 19931552 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
10.17 | 11884234 19555203 |
MESH:D008175 |
Lung Neoplasms |
|
Vitamin E |
10.17 | 11062179 |
MESH:D008223 |
Lymphoma |
|
Benzene |
3.55 | 17119257 17584886 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
4.06 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
3.66 | 14749477 |
MESH:D016399 |
Lymphoma, T-Cell |
marker/mechanism |
|
| 15375218 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Benzene |
9.38 | 12562636 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
9.38 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Benzene |
9.17 | 11921183 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
9.17 | 17203775 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
9.17 | 8985016 11606380 |
MESH:D008545 |
Melanoma |
|
resveratrol |
3.34 | 17992120 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
3.34 | 16487513 19082730 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.31 | 19513568 |
MESH:D008607 |
Mental Retardation |
|
Toluene |
3.56 | 9294310 |
MESH:D008654 |
Mesothelioma |
|
Asbestos, Crocidolite |
3.08 | 18303189 16166281 16966607 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
4.14 | 17112576 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.52 | 16801185 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.29 | 15863610 |
MESH:D019957 |
Motor Skills Disorders |
|
Toluene |
4.99 | 9294310 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
2.99 | 16381670 |
MESH:D009101 |
Multiple Myeloma |
|
Benzene |
11.19 | 17119195 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
11.19 | 16497877 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
11.19 | 16490592 17164350 14749477 16267019 17935668 17049120 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
4.61 | 17962980 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.25 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
5.37 | 19151258 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
5.37 | 17015251 17125593 17188708 16317513 16525036 16456233 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
8.33 | 17125593 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
8.33 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.75 | 16411023 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.50 | 17322642 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
5.29 | 16343187 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
9.47 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
9.47 | 7678174 18551238 |
MESH:D009369 |
Neoplasms |
|
4-phenylbutyric acid |
14.37 | 19116145 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
14.37 | 11141357 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
14.37 | 17405874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
14.37 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Trichloroethylene |
14.37 | 11911487 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
8.37 | 8985016 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
8.37 | 20056578 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.17 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.06 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
2.96 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
Benzene |
6.98 | 15643154 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
6.98 | 12854658 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
7.65 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
7.65 | 17652729 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
4.16 | 17929310 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.75 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
13.85 | 16049721 12819281 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
13.85 | 16049721 |
MESH:D009784 |
Occupational Diseases |
|
Benzene |
13.85 | 15612468 15913788 15576619 15727169 17119257 17178637 15935809 16737584 17479406 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
3.24 | 15775268 17882678 19059307 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
9.40 | 17893378 15579764 17823083 15758505 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
9.40 | 17513867 |
MESH:D010051 |
Ovarian Neoplasms |
|
Benzene |
7.50 | 12562636 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
7.50 | 16525653 17393432 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
7.50 | 15276417 17306315 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.19 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
gemcitabine |
3.44 | 17440100 18992248 11504793 18383843 16929163 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.98 | 12520081 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Crocidolite |
4.63 | 10923243 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
4.29 | 12224865 11605937 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.31 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.00 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
8.72 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
8.72 | 11399792 11118676 11222880 11896295 |
MESH:D011471 |
Prostatic Neoplasms |
|
AGN 194204 |
1.88 | 16000583 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
1.88 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
1.88 | 16536755 15731164 16220300 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
1.88 | 15767336 17636462 17718901 17675339 16731767 17804756 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
1.88 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Vitamin E |
1.88 | 15084515 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.14 | 16882103 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Crocidolite |
2.93 | 15814490 17975199 17365031 17322281 |
MESH:D011693 |
Purpura |
|
Raloxifene |
5.29 | 15770314 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.32 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
6.14 | 19058328 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
6.14 | 16317513 16314181 15827377 17520802 17058453 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.56 | 10835634 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.59 | 18990726 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.76 | 18045962 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
8.92 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
8.92 | 18551238 |
MESH:D012640 |
Seizures |
|
Toluene |
8.92 | 6431079 9294310 |
MESH:D012871 |
Skin Diseases |
|
Vitamin E |
2.37 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
12.54 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
12.54 | 8985016 15837718 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
12.54 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
12.54 | 16192470 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.02 | 16503802 15862959 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.60 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzene |
2.51 | 12562636 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.51 | 20155912 2093021 |
MESH:D020521 |
Stroke |
|
Raloxifene |
8.03 | 16837676 |
MESH:D020521 |
Stroke |
|
Vitamin E |
8.03 | 16517955 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.25 | 16321402 |
MESH:D013733 |
Testicular Diseases |
|
Toluene |
4.69 | 10514026 10048760 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
3.94 | 15821434 |
MESH:D013953 |
Thymus Neoplasms |
|
Benzene |
4.69 | 10850423 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.64 | 12697716 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
4.94 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
3.98 | 16227395 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
14.68 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
14.68 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
14.68 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
14.68 | 17572228 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
14.68 | 16712894 16452187 17306315 11723127 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
11.11 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
11.11 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.74 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
8.81 | 17473185 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
8.81 | 11813266 |
MESH:D014594 |
Uterine Neoplasms |
|
Benzene |
9.04 | 12562636 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
9.04 | 17044934 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.72 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.16 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.33 | 12125929 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
4.94 | 16837676 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
4.04 | 17488730 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.29 | 16343187 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.98 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.17 | 17120751 |